EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE
<p>Aim. To evaluate dynamics of endothelial vasoregulatory function in type 2 diabetic patients after 6 months of combined treatment with atorvastastin 20 mg/day depending on the disease duration and target lipid levels achievement.<br />Material and methods. The total of 161 type 2 diab...
Main Authors: | G. A. Batrak, S. E. Miasoedova, O. I. Kelesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/60 |
Similar Items
-
Lipidkorrigiruyushchie effekty nizkoy dozy atorvastatina u bol'nykh sakharnym diabetom tipa 2 i ozhireniem
by: M G Bubnova, et al.
Published: (2003-03-01) -
Novye vozmozhnosti korrektsii disfunktsiiendoteliya u bol'nykh insulinrezistentnymsakharnym diabetom 2 tipa
by: T Yu Demidova, et al.
Published: (2006-09-01) -
Diastolicheskaya funktsiya miokarda i avtonomnaya kardial'naya neyropatiya u detey pri sakharnom diabete tipa 1
by: I G Kuznetsova, et al.
Published: (2002-06-01) -
Effect of adenylate cyclases activator on the cytoskeleton reorganization in thrombin-induced endothelial barrier dysfunction
by: I B Alieva, et al.
Published: (2011-09-01) -
Evaluating efficacy and safety of differential therapy with atorvastatin, fenofibrate and their combination in patients with type 2 diabetes
by: G. A. Batrak
Published: (2015-12-01)